Oncology · Gynecologic Oncology
The facts most likely to be tested
Gestational Trophoblastic Neoplasia (GTN) is diagnosed by a plateau or rise in serum beta-hCG levels following the evacuation of a molar pregnancy.
The most common clinical presentation of GTN is abnormal uterine bleeding occurring after a pregnancy event, often accompanied by an enlarged uterus inconsistent with dates.
Choriocarcinoma is a highly malignant form of GTN that frequently presents with early hematogenous metastasis to the lungs, causing symptoms like cough or hemoptysis.
Theca lutein cysts are common in GTN due to high levels of beta-hCG stimulating the ovaries, which typically resolve spontaneously after treatment.
Methotrexate or actinomycin D is the first-line chemotherapy treatment for low-risk GTN.
FIGO staging for GTN incorporates both anatomical spread and a prognostic scoring system based on risk factors like age, antecedent pregnancy, and beta-hCG levels.
Patients must use reliable contraception for at least 6 to 12 months following the completion of chemotherapy to prevent pregnancy and allow for accurate beta-hCG monitoring.
Vignette unlocked
A 28-year-old G2P1 woman presents with persistent vaginal spotting three months after a suction curettage for a complete hydatidiform mole. She reports a mild cough and shortness of breath. Physical examination reveals a soft, slightly enlarged uterus and no adnexal masses. Her serum beta-hCG level is 45,000 mIU/mL, which has increased from 12,000 mIU/mL two weeks ago. A chest X-ray shows multiple bilateral pulmonary nodules.
What is the most appropriate next step in management?
Multi-agent chemotherapy (e.g., EMA-CO regimen)
The patient has high-risk GTN (FIGO score >7) evidenced by pulmonary metastases and rising beta-hCG, necessitating multi-agent chemotherapy rather than single-agent therapy.
Full handout
High yield triage
Etiology / Epidemiology
Arises from abnormal fertilization; extremes of maternal age (<20 or >35) and prior molar pregnancy are primary risk factors.
Clinical Manifestations
Presents with preeclampsia before 20 weeks, vaginal bleeding, and grape-like vesicles on ultrasound.
Diagnosis
Diagnosed via serial beta-hCG monitoring; plateau or rise in titers confirms malignancy.
Treatment
Methotrexate is the first-line agent for low-risk disease; avoid pregnancy for 12 months post-treatment.
Prognosis
Highly curable with >90% survival rate; requires strict adherence to post-treatment surveillance.
Full handout
Epidemiology & Etiology
GTN follows a molar pregnancy in 15-20% of cases. Asian descent is a significant demographic risk factor. It results from abnormal trophoblastic proliferation following fertilization.
Pertinent Anatomy
The pathology involves the chorionic villi of the placenta. Excessive proliferation leads to uterine enlargement exceeding gestational age.
Pathophysiology
Complete moles are typically 46,XX (paternal origin), while partial moles are triploid. Malignant transformation involves persistent, invasive trophoblastic tissue that produces excessive beta-hCG.
Clinical Manifestations
Patients present with vaginal bleeding and hyperemesis gravidarum due to high hormone levels. Uterine size is often larger than dates. Thyrotoxicosis may occur due to TSH-like activity of high hCG. Look for theca lutein cysts on pelvic exam.
Diagnosis
The gold standard is serial beta-hCG monitoring. Diagnosis of GTN is confirmed if hCG plateaus for 4 values over 3 weeks or rises for 3 values over 2 weeks. Chest X-ray is mandatory to rule out pulmonary metastasis.
Treatment
Methotrexate is the first-line treatment for low-risk GTN. Contraindications include hepatic or renal impairment. High-risk disease requires EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine).
Prognosis
Prognosis is excellent with >90% cure rate. Patients must use reliable contraception for 12 months to prevent pregnancy, which would confound hCG monitoring.
Differential Diagnosis
Ectopic pregnancy: adnexal mass vs. uterine mass
Spontaneous abortion: lack of grape-like vesicles
Multiple gestation: normal hCG rise pattern
Hyperemesis gravidarum: absence of uterine enlargement
Placenta previa: painless bleeding in 3rd trimester